Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mar Drugs
2021 Dec 14;1912:. doi: 10.3390/md19120705.
Show Gene links
Show Anatomy links
The 3/4- and 3/6-Subfamily Variants of α-Conotoxins GI and MI Exhibit Potent Inhibitory Activity against Muscular Nicotinic Acetylcholine Receptors.
Ma X
,
Huang Q
,
Yu S
,
Xu S
,
Huang Y
,
Zhao Z
,
Xiao X
,
Dai Q
.
???displayArticle.abstract???
α-Conotoxins GI and MI belong to the 3/5 subfamily of α-conotoxins and potently inhibit muscular nicotinic acetylcholine receptors (nAChRs). To date, no 3/4- or 3/6-subfamily α-conotoxins have been reported to inhibit muscular nAChRs. In the present study, a series of new 3/4-, 3/6-, and 3/7-subfamily GI and MI variants were synthesized and functionally characterized by modifications of loop2. The results show that the 3/4-subfamily GI variant GI[∆8G]-II and the 3/6-subfamily variants GI[+13A], GI[+13R], and GI[+13K] displayed potent inhibition of muscular nAChRs expressed in Xenopus oocytes, with an IC50 of 45.4-73.4 nM, similar to or slightly lower than that of wild-type GI (42.0 nM). The toxicity of these GI variants in mice appeared to be about a half to a quarter of that of wild-type GI. At the same time, the 3/7-subfamily GI variants showed significantly lower in vitro potency and toxicity. On the other hand, similar to the 3/6-subfamily GI variants, the 3/6-subfamily MI variants MI[+14R] and MI[+14K] were also active after the addition of a basic amino acid, Arg or Lys, in loop2, but the activity was not maintained for the 3/4-subfamily MI variant MI[∆9G]. Interestingly, the disulfide bond connectivity "C1-C4, C2-C3" in the 3/4-subfamily variant GI[∆8G]-II was significantly more potent than the "C1-C3, C2-C4" connectivity found in wild-type GI and MI, suggesting that disulfide bond connectivity is easily affected in the rigid 3/4-subfamily α-conotoxins and that the disulfide bonds significantly impact the variants' function. This work is the first to demonstrate that 3/4- and 3/6-subfamily α-conotoxins potently inhibit muscular nAChRs, expanding our knowledge of α-conotoxins and providing new motifs for their further modifications.
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009, Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Becchetti,
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy.
2015,
Pubmed
Benie,
Solution structure of alpha-conotoxin SI.
2000,
Pubmed
Bertrand,
The wonderland of neuronal nicotinic acetylcholine receptors.
2018,
Pubmed
Cai,
Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity.
2018,
Pubmed
Chen,
Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3.
2018,
Pubmed
,
Xenbase
Chi,
Solution conformation of alphaA-conotoxin EIVA, a potent neuromuscular nicotinic acetylcholine receptor antagonist from Conus ermineus.
2003,
Pubmed
Cisterna,
Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation.
2020,
Pubmed
Faragó,
Solution Structure and Acid-Base Properties of Reduced α-Conotoxin MI.
2021,
Pubmed
Favreau,
Biochemical characterization and nuclear magnetic resonance structure of novel alpha-conotoxins isolated from the venom of Conus consors.
1999,
Pubmed
Giribaldi,
Synthesis, Structure and Biological Activity of CIA and CIB, Two α-Conotoxins from the Predation-Evoked Venom of Conus catus.
2018,
Pubmed
Gray,
Peptide toxins from Conus geographus venom.
1981,
Pubmed
Gray,
Conotoxin GI: disulfide bridges, synthesis, and preparation of iodinated derivatives.
1984,
Pubmed
Gray,
Conotoxin MI. Disulfide bonding and conformational states.
1983,
Pubmed
Groebe,
Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
1997,
Pubmed
Han,
NMR structure determination of a novel conotoxin, [Pro 7,13] alpha A-conotoxin PIVA.
1997,
Pubmed
Hann,
The 9-arginine residue of alpha-conotoxin GI is responsible for its selective high affinity for the alphagamma agonist site on the electric organ acetylcholine receptor.
1997,
Pubmed
He,
Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains.
2008,
Pubmed
Hoggard,
In vivo and in vitro testing of native α-conotoxins from the injected venom of Conus purpurascens.
2017,
Pubmed
,
Xenbase
Hone,
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
2018,
Pubmed
Jin,
Conotoxins: Chemistry and Biology.
2019,
Pubmed
Kennedy,
α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.
2020,
Pubmed
Labarca,
Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors.
1995,
Pubmed
,
Xenbase
Lebbe,
Conotoxins targeting nicotinic acetylcholine receptors: an overview.
2014,
Pubmed
Li,
Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
2021,
Pubmed
López-Vera,
A novel alpha conotoxin (alpha-PIB) isolated from C. purpurascens is selective for skeletal muscle nicotinic acetylcholine receptors.
2007,
Pubmed
Martinez,
alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity.
1995,
Pubmed
Maslennikov,
Two distinct structures of alpha-conotoxin GI in aqueous solution.
1998,
Pubmed
Myers,
alpha-Conotoxins, small peptide probes of nicotinic acetylcholine receptors.
1991,
Pubmed
Ning,
Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
2018,
Pubmed
,
Xenbase
Papineni,
Site-specific charge interactions of alpha-conotoxin MI with the nicotinic acetylcholine receptor.
2001,
Pubmed
Peigneur,
Structure-Function Elucidation of a New α-Conotoxin, MilIA, from Conus milneedwardsi.
2019,
Pubmed
,
Xenbase
Quinton,
Identification and functional characterization of a novel α-conotoxin (EIIA) from Conus ermineus.
2013,
Pubmed
Robinson,
Conotoxin gene superfamilies.
2014,
Pubmed
Rybin,
αM-Conotoxin MIIIJ Blocks Nicotinic Acetylcholine Receptors at Neuromuscular Junctions of Frog and Fish.
2020,
Pubmed
,
Xenbase
Tae,
Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
2021,
Pubmed
,
Xenbase
Teichert,
A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase
Teichert,
AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
2004,
Pubmed
Turner,
Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors.
2019,
Pubmed
Ved,
A Review on Emerging Drug Targets in Treatment of Schizophrenia.
2020,
Pubmed
Wang,
Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
2015,
Pubmed
Wonnacott,
Nicotinic acetylcholine receptors.
2018,
Pubmed
Wu,
The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.
2015,
Pubmed
Zoli,
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.
2018,
Pubmed